| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-644-90 | 62135-644 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA208920 | Chartwell RX, LLC | LISINOPRIL | 30 mg/1 | 90 TABLET in 1 BOTTLE (62135-644-90) |
| 62135-645-31 | 62135-645 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA208920 | Chartwell RX, LLC | LISINOPRIL | 40 mg/1 | 300 TABLET in 1 BOTTLE (62135-645-31) |
| 62135-645-90 | 62135-645 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA208920 | Chartwell RX, LLC | LISINOPRIL | 40 mg/1 | 90 TABLET in 1 BOTTLE (62135-645-90) |
| 62135-644-31 | 62135-644 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA208920 | Chartwell RX, LLC | LISINOPRIL | 30 mg/1 | 300 TABLET in 1 BOTTLE (62135-644-31) |
| 62135-643-90 | 62135-643 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA208920 | Chartwell RX, LLC | LISINOPRIL | 20 mg/1 | 90 TABLET in 1 BOTTLE (62135-643-90) |
| 62135-643-31 | 62135-643 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA208920 | Chartwell RX, LLC | LISINOPRIL | 20 mg/1 | 300 TABLET in 1 BOTTLE (62135-643-31) |